The safety and serious adverse events of approved ALK inhibitors in malignancies: a meta-analysis

DOI: 10.2147/CMAR.S190098

Keywords: ALK inhibitors, safety, serious adverse events, lung toxicity

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text